ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Targeting O-GlcNAcylated METTL3 impedes MDS/AML progression via diminishing SRSF1 m

Junjie Gou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.